Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 20 | 0 | 550 | 225 | 50 |
| Gross Profit | 20 | N/A | 550 | 225 | 50 |
| Operating Expenses | 5,854 | 7,077 | 5,536 | 5,344 | 4,842 |
| Operating Income | -5,834 | -7,077 | -4,986 | -5,119 | -4,792 |
| Interest Expense | 0 | 0 | 0 | -1 | 1 |
| Other Income | 922 | 17 | 24 | 40 | 34 |
| Pre-tax Income | -4,912 | -7,060 | -4,962 | -5,078 | -4,759 |
| Net Income Continuous | -4,912 | -7,060 | -4,962 | -5,078 | -4,759 |
| Net Income | $-4,912 | $-7,060 | $-4,962 | $-5,078 | $-4,759 |
| EPS Basic Total Ops | -15.25 | -24.54 | -20.89 | -22.17 | -23.39 |
| EPS Basic Continuous Ops | -15.25 | -24.51 | -20.85 | -23.27 | -23.44 |
| EPS Diluted Total Ops | -15.25 | -24.54 | -20.89 | -22.17 | -23.39 |
| EPS Diluted Continuous Ops | -15.25 | -24.51 | -20.85 | -23.27 | -23.44 |
| EPS Diluted Before Non-Recurring Items | -15.27 | -25.20 | -21.00 | -23.10 | N/A |
| EBITDA(a) | $-5,803 | $-7,047 | $-4,955 | $-5,074 | $-4,725 |